European Committee for Treatment and Research in Multiple Sclerosis

Lipoic acid shows great potential as a disease modifying treatment for secondary progressive MS: ECTRIMS congress

The 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (MS) continued today in London (September 14-17). One of the parallel sessions reported promising early results on the potential benefits of lipoic acid in secondary progressive MS.
ECTRIMS Secretariat, Peter Merian-Strasse 80, CH-4002 Basel

+41 (0)61 686 77 79